TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
LFCR

Lifecore Biomedical Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

6.50$ +0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Lifecore Biomedical Inc. (LFCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 230 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LFCR
Line item Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q1 26 Q2 26
343 344 341 346 358 367 379 386 405 403 412 502 519 546 560 550 541 506 499 510 503 446 422 326 295 295 279 279 236 246 246 254 254 247 255 238 239 235 225 230
86 88 84 87 81 89 96 94 97 88 92 114 133 131 140 149 157 147 154 163 148 142 155 132 124 124 127 127 88 83 77 94 81 74 82 84 86 84 78 84
9.9 8.6 2.6 13 5.4 8.2 4.4 7.7 2.9 1.4 1.5 1.7 1.1 2.0 1.6 2.6 0.4 0.6 2.5 2.2 1.2 1.4 1.1 1.9 1.6 1.6 6.8 6.8 3.0 8.6 3.2 19 8.5 5.5 9.5 5.4 8.3 19 21 17
9.9 8.6 2.6 13 5.4 8.2 4.4 7.7 2.9 1.4 1.5 1.7 1.1 2.0 1.6 2.6 0.4 0.6 2.5 2.2 1.2 1.4 1.1 1.9 1.6 1.6 – 6.8 3.0 – – 19 8.5 5.5 9.5 5.4 8.3 19 21 17
46 44 50 46 46 48 56 50 54 49 53 60 70 61 70 70 76 65 67 70 41 62 65 50 48 48 36 36 32 27 30 29 31 25 20 19 44 29 27 30
26 30 28 23 25 28 31 29 32 30 32 44 54 55 59 67 66 60 71 77 63 69 79 74 67 67 78 78 49 42 41 41 40 42 39 35 32 34 28 25
– – – – – – – – – – – – – – – – – – – – – – 192 132 139 137 127 119 121 – – – – – – – – – – –
50 50 50 50 55 55 55 55 55 55 55 76 77 77 77 77 69 69 69 69 34 69 37 34 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14
21 21 21 21 23 23 22 22 22 22 21 48 45 45 44 44 38 38 37 37 26 36 35 25 16 16 8.7 8.7 4.4 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 –
131 127 122 122 130 136 147 136 152 150 158 232 249 281 301 302 310 285 290 305 300 252 266 182 187 187 205 205 202 259 244 258 243 251 240 235 238 198 205 213
57 53 47 47 51 58 70 71 88 87 97 119 137 147 144 158 164 154 174 125 102 104 122 90 79 79 196 196 38 35 40 39 39 41 35 31 30 30 20 22
11 7.9 6.4 4.9 7.9 15 15 17 32 44 47 54 62 84 77 74 93 84 92 45 31 36 45 45 46 46 – 152 1.5 – – 1.9 4.9 4.9 4.9 4.9 3.8 1.3 1.3 1.0
31 32 26 25 25 27 37 35 35 27 32 46 54 46 47 64 52 51 61 56 16 46 59 20 16 16 28 28 15 16 19 22 16 18 15 7.4 8.2 10 6.6 7.5
– – – – – – – – – – – – – – – – – – – – – 124 124 80 98 96 – 115 99 107 109 116 121 127 119 124 127 135 142 149
211 215 218 223 227 230 231 249 253 253 254 270 270 265 259 248 231 221 209 205 203 194 156 144 108 108 74 74 34 -14 1.4 -4.2 11 -3.9 15 2.2 1.3 37 21 16
73 77 79 82 84 87 87 103 109 109 109 110 110 105 98 86 71 60 47 41 39 29 -9.3 -22 -59 -59 -100 -100 -140 -189 -175 -179 -167 -183 -191 -204 -205 -218 -238 -244
27 28 28 28 28 28 28 28 28 28 28 29 29 29 29 29 29 29 29 29 29 29 29 29 30 30 30 30 30 30 30 30 31 31 34 37 37 37 37 38

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?